0001209191-22-018065.txt : 20220310 0001209191-22-018065.hdr.sgml : 20220310 20220310200729 ACCESSION NUMBER: 0001209191-22-018065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220308 FILED AS OF DATE: 20220310 DATE AS OF CHANGE: 20220310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TOBIN JAMES R CENTRAL INDEX KEY: 0001190128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 22730816 MAIL ADDRESS: STREET 1: C/O CURIS INC STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-08 0 0001237831 GLOBUS MEDICAL INC GMED 0001190128 TOBIN JAMES R VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 1 0 0 0 Class A Common Stock 2022-03-08 4 M 0 4484 43.58 A 4484 D Class A Common Stock 2022-03-08 4 S 0 4484 72.00 D 0 D Class A Common Stock 2022-03-10 4 M 0 10000 43.58 A 10000 D Class A Common Stock 2022-03-10 4 S 0 10000 70.0398 D 0 D Stock Option (Right to Buy Class A Common Stock) 43.58 2022-03-08 4 M 0 4484 0.00 D 2029-01-22 Class A Common Stock 4484 20516 D Stock Option (Right to Buy Class A Common Stock) 43.58 2022-03-10 4 M 0 10000 0.00 D 2029-01-22 Class A Common Stock 10000 10516 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.135, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. These options were granted on January 22, 2019 and are fully vested. /s/ Kelly G. Huller, Attorney-in-Fact 2022-03-10